Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma

Journal of Clinical Investigation

Volumn 126, Issue 6, 2016, Pages 2367-2371

  Bonser, Luke R ^a   Zlock, Lorna ^a   Finkbeiner, Walter ^a   Erle, David J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; MUCIN 5AC; MUCIN 5B; GEL; MUC5AC PROTEIN, HUMAN; MUC5B PROTEIN, HUMAN;

ARTICLE; ASTHMA; CILIARY MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MUCOCILIARY TRANSPORT; MUCUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; AIRWAY OBSTRUCTION; CASE CONTROL STUDY; COMPLICATION; GEL; METABOLISM; MUCOCILIARY CLEARANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY MUCOSA;

AIRWAY OBSTRUCTION; ASTHMA; CASE-CONTROL STUDIES; GELS; HUMANS; MUCIN 5AC; MUCIN-5B; MUCOCILIARY CLEARANCE; MUCUS; RESPIRATORY MUCOSA;

EID: 84974623218     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI84910     Document Type: Article

References (24)

1. Croisant S. Epidemiology of asthma: prevalence and burden of disease. Adv Exp Med Biol. 2014;795:17-29.
2. Bateman JR, Pavia D, Sheahan NF, Agnew JE, Clarke SW. Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax. 1983;38(6):463-467.
3. Messina MS, O'Riordan TG, Smaldone GC. Changes in mucociliary clearance during acute exacerbations of asthma. Am Rev Respir Dis. 1991;143(5 pt 1):993-997.
4. Messer JW, Peters GA, Bennett WA. Causes of death and pathologic findings in 304 cases of bronchial asthma. Dis Chest. 1960;38:616-624.
5. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest. 1992;101(4):916-921.
6. Kuyper LM, et al. Characterization of airway plugging in fatal asthma. Am J Med. 2003;115(1):6-11.
7. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest. 2002;109(5):571-577.
8. Button B, et al. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science. 2012;337(6097):937-941.
9. Hoegger MJ, et al. Cystic fibrosis. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science. 2014;345(6198):818-822.
10. Thornton DJ, Rousseau K, McGuckin MA. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol. 2008;70:459-486.
11. Groneberg DA, et al. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir Med. 2002;96(2):81-86.
12. Roy MG, et al. Muc5b is required for airway defence. Nature. 2013;505(7483):412-416.
13. Evans CM, et al. The polymeric mucin Muc5ac is required for allergic airway hyperreactivity. Nat Commun. 2015;6:6281.
14. Kuperman DA, Huang X, Nguyenvu L, Holscher C, Brombacher F, Erle DJ. IL-4 receptor signaling in Clara cells is required for allergen-induced mucus production. J Immunol. 2005;175(6):3746-3752.
15. Kuperman DA, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med. 2002;8(8):885-889.
16. Woodruff PG, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180(5):388-395.
17. Kirkham S, Sheehan JK, Knight D, Richardson PS, Thornton DJ. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J. 2002;361(pt 3):537-546.
18. Sheehan JK, Richardson PS, Fung DC, Howard M, Thornton DJ. Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus. Am J Respir Cell Mol Biol. 1995;13(6):748-756.
19. -/- baseline secretion defect reveals source of oligomeric mucins in mouse airways. J Physiol. 2008;586(7):1977-1992.
20. Hill DB, et al. A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease. PLoS One. 2014;9(2):e87681.
21. Bermbach S, et al. Mechanisms of cilia-driven transport in the airways in the absence of mucus. Am J Respir Cell Mol Biol. 2014;51(1):56-67.
22. Rogers DF. Airway mucus hypersecretion in asthma: an undervalued pathology? Curr Opin Pharmacol. 2004;4(3):241-250.
23. Shimura S, Andoh Y, Haraguchi M, Shirato K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J. 1996;9(7):1395-1401.
24. Corren J, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365(12):1088-1098.